open access

Vol 47, No 1 (2009)
Original paper
Submitted: 2011-12-19
Published online: 2009-05-08
Get Citation

Advanced differentiation in trichoepithelioma and basal cell carcinoma investigated by immunohistochemistry against neurofilaments.

Angel Fernandez-Flores
DOI: 10.2478/v10042-009-0011-5
·
Folia Histochem Cytobiol 2009;47(1):61-64.

open access

Vol 47, No 1 (2009)
ORIGINAL PAPERS
Submitted: 2011-12-19
Published online: 2009-05-08

Abstract

Basal cell carcinoma (BCC) and trichoepithelioma (TE) are sometimes diagnostic challenges for the pathologist in terms of their differential diagnosis. Although literature is quite rich in information about histologic and immunohistochemical clues to distinguish the differences between both, no single finding must be completely reliable. Moreover, some consider that TE is a better differentiated follicular tumour, while BCC represents a less developed stage in differentiation. For instance, the latter opinion is supported by the evidence of follicular papillae in TE.The formation of a perifollicular nerve plexus happens later than the formation of the follicular papillae in the development of a normal follicle. The study of the presence of the perifollicular nerve plexus in both tumours which could then provide us with evidence on the stage of differentiation of both tumours. 5 cases of TE and 10 cases of BCC were randomly selected from our archives and an immunohistochemical study for neurofilaments was performed in all the cases.We found a peritumoural nerve plexus in all the cases (TEs and BCCs). Since this plexus is a late sign of differentiation and since both types of neoplasias share it, we conclude that TE and BCC are both terminally differentiated neoplasms. The ability of BCC to infiltrate would have more to do with the acquisition by the tumour of such a property, rather than with a stage of indifferentiation.

Abstract

Basal cell carcinoma (BCC) and trichoepithelioma (TE) are sometimes diagnostic challenges for the pathologist in terms of their differential diagnosis. Although literature is quite rich in information about histologic and immunohistochemical clues to distinguish the differences between both, no single finding must be completely reliable. Moreover, some consider that TE is a better differentiated follicular tumour, while BCC represents a less developed stage in differentiation. For instance, the latter opinion is supported by the evidence of follicular papillae in TE.The formation of a perifollicular nerve plexus happens later than the formation of the follicular papillae in the development of a normal follicle. The study of the presence of the perifollicular nerve plexus in both tumours which could then provide us with evidence on the stage of differentiation of both tumours. 5 cases of TE and 10 cases of BCC were randomly selected from our archives and an immunohistochemical study for neurofilaments was performed in all the cases.We found a peritumoural nerve plexus in all the cases (TEs and BCCs). Since this plexus is a late sign of differentiation and since both types of neoplasias share it, we conclude that TE and BCC are both terminally differentiated neoplasms. The ability of BCC to infiltrate would have more to do with the acquisition by the tumour of such a property, rather than with a stage of indifferentiation.
Get Citation
About this article
Title

Advanced differentiation in trichoepithelioma and basal cell carcinoma investigated by immunohistochemistry against neurofilaments.

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 47, No 1 (2009)

Article type

Original paper

Pages

61-64

Published online

2009-05-08

DOI

10.2478/v10042-009-0011-5

Bibliographic record

Folia Histochem Cytobiol 2009;47(1):61-64.

Authors

Angel Fernandez-Flores

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl